Allogene Therapeutics Inc (NASDAQ: ALLO): Analyst View Points To Future Growth
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.17, with 2.86 million shares of worth about $6.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.07% during that period and on December 26, 2024 the price saw a […]
Allogene Therapeutics Inc (NASDAQ: ALLO): To Buy Or Not To Buy, That Is The Question
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.02, with 2.73 million shares of worth about $5.52 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.47% during that period and on December 12, 2024 the price saw a […]
Do Allogene Therapeutics Inc (NASDAQ: ALLO) Fit In A Value Investing Philosophy?
Currently, there are 167.13M common shares owned by the public and among those 142.43M shares have been available to trade. The company’s stock has a 5-day price change of 18.87% and -1.95% over the past three months. ALLO shares are trading -21.50% year to date (YTD), with the 12-month market performance down to -0.79% lower. […]
Allogene Therapeutics Inc (NASDAQ: ALLO) – Not A Clear Buying Opportunity?
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $2.77, with 3.3 million shares of worth about $9.15 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.88% during that period and on October 23, 2024 the price saw a […]
Growth Story Still Intact For Allogene Therapeutics Inc (ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.61, with 2.65 million shares of worth about $6.91 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.56% during that period and on October 03, 2024 the price saw a […]
Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $4.15, with 4.08 million shares of worth about $16.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.95% during that period and on Wednesday February 7 the price saw a […]
Analyst Expect Big Moves From Allogene Therapeutics Inc (NASDAQ: ALLO)
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
